Volume 23 - Issue 2 - February 2011
Now How Did That Happen?
- Tue, 2/8/11 - 10:36am
- 0 Comments
- 2052 reads
Have you ever heard of the law of unintended consequences? It says that actions always have an unanticipated or unintended effect.1 No matter how pure and well-meaning one’s intentions, any action may not turn out exactly how imagined. This can especially true when dealing with governments. One classic example involves the impoverished people of Haiti. The world community has come to the aid of the Haitians even before the hurricane, the cholera epidemic, and the floods. Much of this help has been in the form of food—corn, beans, and other produce.
Perioperative and Postoperative Blood Loss
- Tue, 2/8/11 - 10:48am
- 0 Comments
- 2619 reads
Dear Readers:
The Effects of Aloe Vera Cream on Split-thickness Skin Graft Donor Site Management: A Randomized, Blinded, Placebo-controlled Study
- Tue, 2/8/11 - 11:25am
- 0 Comments
- 5346 reads
Abstract: Purpose. Split-thickness skin graft donor site management is an important patient comfort issue. The present study examined the effects of aloe vera cream compared to placebo cream and gauze dressing on the rates of wound healing and infection at the donor site. Methods. Forty-five patients were enrolled in this randomized clinical trial and divided into three groups: control (without topical agent), placebo (base cream without aloe vera), and aloe vera cream groups. All patients underwent split-thickness skin grafting for various reasons, and the skin graft donor site wounds were covered with single-layer gauze without any topical agent, with aloe vera, or with placebo cream. The donor sites were assessed daily postoperatively until complete healing was achieved. Results. Mean time to complete re-epithelization was 17 ± 8.6, 9.7 ± 2.9, and 8.8 ± 2.8 days for control, aloe vera, and placebo groups, respectively. Mean wound healing time in the control group was significantly different from the aloe vera and placebo groups (P < 0.005). The healing rate was not statistically different between aloe vera and placebo groups. Conclusion. This study showed a significantly shorter wound care time for skin graft donor sites in patients who were treated with aloe vera and placebo creams. The moist maintenance effect of these creams may contribute to wound healing.
Influence of Short-term, Repeated Fasting on the Skin Wound Healing of Female Mice
- Tue, 2/8/11 - 12:16pm
- 0 Comments
- 4728 reads
Abstract: Caloric restriction in mice has been found to retard the rate of aging, increase mean and maximum life spans, and inhibit the occurrence of many age-associated diseases. The following study was conducted to investigate the effect of short-term repeated fasting (4 consecutive days, every 2 weeks) before wound creation on skin wound healing. Mice were used for macroscopic study (n = 40) and hydroxyproline analysis (n = 10). Mice were also used for microscopic study (n = 36) and were divided equally into a fasting group and a control group. The results revealed that there were significant differences in epithelialization, contraction, healing, amount of collagen, and hydroxyproline between the control and fasting groups (P < 0.05). Based on the results, it can be argued that caloric restriction preceding the wound-healing period has the potential to accelerate the healing process.
Mixed Suspension of Cultured Autologous and Allogenic Keratinocytes in Fibrin Glue for the Treatment of Full-thickness Burns
- Tue, 2/8/11 - 12:44pm
- 0 Comments
- 4289 reads
Abstract: In-vitro cultured autologous and allogenic keratinocytes were mixed in single-cell suspension and transplanted for the treatment of full-thickness, third-degree burns. Ten patients were selected according to a protocol approved by the authors’ local Institutional Review Board. After epifascial necrectomy, the burns were temporarily covered with fresh allografts, and a mixed suspension of in-vitro cultured autologous and allogenic keratinocytes in fibrin glue with a density of 107 cells/mL was transplanted to the wounds by injection with a syringe in multipoint underneath the allograft. The grafting density was 5 × 106 cells per 100 cm2. The transplanted keratinocytes proliferated on the epifascial surface and grew into confluent epithelial layer 28 ± 7 days after transplantation. Complete re-epithelialization and stable skin conditions were achieved 62 ± 11 days after transplantation. This method decreased in-vitro cell culture time to 5 days and resulted in permanent re-epithelialization of third-degree burn wounds. To the authors’ knowledge, this is the first report where autologous and allogenic keratinocytes were mixed and transplanted together to treat third-degree burn wounds. The performance and density of the keratinocytes remain to be studied.
Preclinical Evaluation of Antimicrobial Efficacy and Biocompatibility of a Novel Bacterial Barrier Dressing
- Tue, 2/8/11 - 1:53pm
- 0 Comments
- 6951 reads
Abstract: Wounds that become infected can lead to devastating consequences for patients, resulting in substantially increased healthcare costs. Bacterial barrier dressings are a first line of protection against developing wound infections. Most bacterial barrier dressings contain microbicidal chemicals (eg, silver ions, iodine, chlorhexidine) that are released from the dressings, which can be toxic to wound cells. A need exists for cost effective bacterial barrier dressings that absorb wound exudate and do not release toxic materials into the wound or increase the risk for developing bacterial resistance to the microbicidal chemical. The present study reports the development and properties of a novel bacterial barrier dressing that meets these needs. Methods. A high molecular weight (~250 k Daltons) polymer containing a high density of quaternary amines (polydiallyldimethylammonium chloride [polyDADMAC]) was permanently bonded onto cellulose fibers (gauze). Microbicidal and mammalian cell cytotoxicity tests were conducted using standard methods. Development of bacterial resistance to the microbicidal fibers was assessed over 10 passages. Results. The polyquat-treated bacterial barrier gauze dressing (BIOGUARD [BBD]) had high microbicidal activity even in the presence of proteinaceous fluid against a wide range of Gram-positive and Gram-negative bacteria. The BBD dressing passed all mammalian cell toxicity tests due to the non-leaching of the bactericidal polymer. Furthermore, the BBD dressing did not demonstrate any ability to induce bacterial resistance in selection vector testing. Conclusion. This novel dressing featuring a bound microbicide offers another choice for wound caregivers to provide patients with an antimicrobial barrier dressing safe enough for prophylactic use to protect against wound infections.
Executive Spotlight: Kimberly Herman, President, Chronic Care, Coloplast Corp
- Tue, 2/8/11 - 3:39pm
- 0 Comments
- 1990 reads
Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use their products, Coloplast creates solutions that are sensitive to their special needs. Kimberly Herman, President of Chronic Care provides and in-depth look inside this remarkable business that includes ostomy care, continence care, and wound and skin care. The following interview offers a glimpse as to what it takes for a healthcare company to operate globally and employ more than 7,000 people.
Use of a New Antimicrobial Dressing (TheraBond) on a Non-healing Wound
- Wed, 2/9/11 - 12:37pm
- 0 Comments
- 2217 reads
Abstract: The wound care specialist is often confronted with wounds previously treated with many different products that remain resistant to closure. This report describes the use of a new antimicrobial dressing (TheraBond 3D, Choice Therapeutics, Wrentham, MA) to close a perineal wound in an area that had been radiated prior to abdominal-perineal resection to treat colon cancer. The rapid healing achieved warrants further investigation of this novel dressing.
Case Report
Putting Salt in My Wound Center: Lower Reimbursements for Preventative Services Will Mean More Amputations
- Mon, 1/24/11 - 12:15pm
- 0 Comments
- 3578 reads
From the Amputation Prevention Center at Valley Presbyterian Hospital, Los Angeles, California
Address correspondence to:
Lee C. Rogers, DPM
15107 Vanowen St.
Van Nuys, CA 91405
Phone: 818-902-5755
Email: lee.c.rogers@gmail.com






